جست‌وجوی استاد و پژوهشگر

• Immunology
• Genomics
• Multiomics Analysis
• +۳ مورد دیگر

Calliope Dendrou is an Associate Professor in Clinical Pathology and Inflammation at the Kennedy Institute of Rheumatology (KIR), University of Oxford, leading the Immune Disease Multiomics Laboratory. She previously held a Wellcome & Royal Society Sir Henry Dale Fellowship at the University of Oxford’s Centre for Human Genetics before joining KIR in 2023. Her research focuses on immune disease mechanisms using multiomics approaches, including genomic profiling to identify therapeutic targets across tissues and immune-mediated diseases. She co-leads large-scale projects like the Oxford-J&J Cartography Consortium and the Chan Zuckerberg Initiative’s LEGACY Network, and teaches on the MSc in Genomic Medicine program. Educational Background: BSc (Biology, Imperial College London, 2005; Forbes Memorial Medal Winner); PhD in Infection & Immunity (University of Cambridge, 2010). Postdoctoral training at the Weatherall Institute of Molecular Medicine under Prof. Lars Fugger. Research interests include immunogenetics, cytokine signaling pathways, drug repositioning, and cross-disease pathophysiology. Her work integrates single-cell and spatial transcriptomics to dissect immune-cell interactions in diseases like rheumatoid arthritis, inflammatory bowel disease, and celiac disease. Recent articles highlight her contributions to understanding vaccine adjuvant responses, Th17 cell roles in spondyloarthritis, and immune-epithelial networks in celiac disease. Collaborations emphasize multi-omic data analysis (e.g., Panpipes pipeline) and translational studies toward precision medicine. Awards: Forbes Memorial Medal (BSc), Wellcome & Royal Society Sir Henry Dale Fellowship. Leadership roles include Equality, Diversity, and Inclusion Champion and 'Single-Cell & Spatial Omics for Precision Medicine' Module Lead. Lab & Teams: Immune Disease Multiomics Lab at KIR. Active in collaborative initiatives such as the LEGACY Network, focusing on large-scale immune profiling in ancestrally diverse populations.

Waldemar Kolanusمشاهده پروفایل

استاد

• Molecular Immunology
• Cell Signaling
• Signal Transduction Pathways
• +۴ مورد دیگر

Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788

Brian Hieمشاهده پروفایل

استادیار

• Machine Learning
• Computational Biology
• Protein Engineering
• +۶ مورد دیگر

Brian Hie is an Assistant Professor of Chemical Engineering at Stanford University , a Dieter Schwarz Foundation Stanford Data Science Faculty Fellow , and an Innovation Investigator at Arc Institute . He leads the Laboratory of Evolutionary Design , focusing on the intersection of biology and machine learning . His prior roles include a Stanford Science Fellow in the Stanford University School of Medicine and a Visiting Researcher at Meta AI . Education: Ph.D. , Electrical Engineering and Computer Science , Massachusetts Institute of Technology (2021) Bachelor’s Degree , Stanford University Research Interests: Brian’s work bridges machine learning and computational biology , with a focus on protein engineering , single-cell RNA sequencing , and viral evolution . His Evolutionary velocity framework predicts protein evolutionary dynamics across timescales, while his Scanorama algorithm enables efficient integration of heterogeneous single-cell datasets. He also develops structure-informed language models for antibody optimization and uncertainty-aware ML for biological discovery. Publication Trends: His recent work (2023) emphasizes structure-based inverse folding for antibody evolution, evolutionary scale modeling , and unsupervised optimization . Earlier studies (2022-2021) cover evolutionary velocity , multi-modal single-cell analysis , and viral escape prediction using natural language analogies. Scientific Awards: Stanford Science Fellow (2021) National Defense Science and Engineering Graduate Fellowship (2019) Advising: He mentors doctoral students including Brandon Ameglio , Garyk Brixi , and Chang M. Yun , with a focus on biological design and computational methods . Labs & Collaborations: His lab collaborates with Bio-X and the Institute for Human-Centered Artificial Intelligence (HAI) , and he maintains affiliations with Sarafan ChEM-H and Stanford Data Science .

Gabriela Minigoمشاهده پروفایل

پژوهشگر

• Immunology
• Microbiology
• Malaria Research
• +۵ مورد دیگر

Gabriela Minigo serves as an Honorary Fellow in Global and Tropical Health and Associate Dean - Learning and Teaching within the Faculty of Health. Her academic profile demonstrates active engagement in malaria immunology research with a recent expansion into circadian rhythm and metabolic health investigations. Dr. Minigo completed her PhD at the University of Melbourne (awarded March 31, 2007) and earned a Master of Clinical Epidemiology from the University of Newcastle (awarded December 8, 2017). Her educational background provides a strong foundation in both basic science and clinical epidemiology. Her primary research focuses on immunological responses to malaria, with particular expertise in T follicular helper cells, dendritic cell function, and regulatory T cells in Plasmodium falciparum and Plasmodium vivax infections. Analysis of her research fingerprint reveals significant contributions to Plasmodium falciparum Immunology and Microbiology (100%), Dendritic Cell Immunology and Microbiology (45%), Regulatory T Cell Immunology and Microbiology (38%), and other related fields. In recent years, she has expanded her research to investigate the relationship between photoperiod, circadian rhythm, and metabolic health, as evidenced by her 2024 publications on these topics. Dr. Minigo's scholarly output shows an evolving research trajectory from fundamental malaria immunology toward interdisciplinary investigations connecting circadian biology with metabolic health. Her recent publications (2022-2024) demonstrate continued strong contributions to malaria immunology while incorporating new dimensions related to light exposure, sleep patterns, and glucose control. She has secured research funding for multiple projects including 'Rainmaker start up- Does exposure to artificial light alter circadian rhythm and glucose control in Australian adults? A pilot study' (2023-2026) where she serves as Co-Investigator, and 'Effect of Extended Photoperiod Exposure on Circadian Rhythm and Glucose Control' (2024-present) where she is Principal Investigator. Previously, she contributed as Chief Investigator C to 'Manipulating T follicular helper cells to improve human malaria vaccines' (2020-2023). As Associate Dean for Learning and Teaching, Dr. Minigo holds significant educational leadership responsibilities within the Faculty of Health. She is registered to supervise postgraduate research, indicating her active role in mentoring graduate students in immunology and tropical medicine research.

Moira Whyteمشاهده پروفایل

استاد

• Respiratory medicine
• Inflammation
• Neutrophil biology
• +۵ مورد دیگر

Moira Whyte serves as Sir John Crofton Professor of Respiratory Medicine and Head of Edinburgh Medical School at the University of Edinburgh, while directing the MRC University of Edinburgh Centre for Inflammation Research. Her leadership spans clinical academia and major research initiatives focused on respiratory pathophysiology. Her educational background includes a 1st Class B.Sc. (1981), M.B., B.S. (1984), and Ph.D. (1993) from the University of London, complemented by professional qualifications: M.R.C.P. (1987), F.R.C.P. (1998), and F.Med.Sci. (2005) from the Academy of Medical Sciences. Whyte's research centers on neutrophil biology, macrophage function, and hypoxia signaling pathways in respiratory diseases. Her work explores how oxygen-sensing mechanisms like HIF pathways regulate immune cell function in COPD, pulmonary fibrosis, and bacterial infections, with particular focus on cellular metabolism and inflammation resolution. Analysis of her 15 most recent publications reveals consistent focus on neutrophil and macrophage biology within respiratory diseases, with growing emphasis on metabolic regulation of immune responses. Her work bridges basic science (using zebrafish models) with clinical applications, particularly in COPD and pulmonary fibrosis. Her scientific recognition includes: 2014 OBE for Services to Respiratory Medicine 2014 Foundation Fellow of the European Respiratory Society 2005 Fellow, Academy of Medical Sciences 2002 Tudor Edwards Lecturer of the Royal College of Physicians 1994 Wellcome Trust Advanced Fellowship 1989 MRC Clinical Training Fellowship Whyte directs substantial research funding, including a £6.4M Wellcome Trust Clinical PhD Programme (ECAT-Plus) and multiple grants investigating macrophage function in COPD, hypoxia pathways in pulmonary fibrosis, and neutrophilic inflammation regulation. Her collaborative approach is evident in multi-institutional projects like the EME-TIPAC study on pulmonary fibrosis. As Director of the MRC Centre for Inflammation Research, she leads a multidisciplinary team investigating fundamental mechanisms of inflammation across multiple disease contexts, with particular strength in respiratory immunology and translational applications.

• Genomic Medicine
• Translational Medicine
• Immunogenetics
• +۴ مورد دیگر

Julian Knight is a Professor of Genomic Medicine at the University of Oxford, with affiliations including the Centre for Human Genetics , Merton College , and leadership roles in the NIHR Oxford Biomedical Research Centre and Central and South NHS Genomic Medicine Service . His work bridges clinical practice and research, focusing on translational genomics. Principal Investigator Deputy Director, Centre for Human Genetics Honorary Consultant Physician Tutor and Fellow, Merton College Director, Medical Sciences Division Graduate School Genomic Medicine Theme Lead, NIHR Oxford BRC Research interests include mechanisms of dysregulated immune responses in sepsis , autoimmune disease , and infection . Key contributions involve RNA signature stratification for sepsis outcomes and HLA allele associations in COVID-19 immunogenicity. Current work explores genetic/epigenetic modulators of innate immunity and causal relationships in multi-omic datasets. Recent publications highlight diverse applications of his group’s work: from pleural infection endotyping (2025) to TLR7 variants in severe COVID-19 (2024), with methodological advancements in single-cell demultiplexing (2024) and pathway analysis (2025). Keywords span genomic medicine , immunology , and multi-omic integration . Knight’s leadership extends to clinical implementation of genomics, education (DPhil/MSc programs), and public engagement. Collaborations span institutions including Imperial College , Wellcome Sanger Institute , and Queen Mary University of London .

Yi David Juمشاهده پروفایل

پژوهشگر ارشد

• Nanotechnology
• mRNA Therapeutics
• Lipid Nanoparticle Formulation
• +۴ مورد دیگر

Dr. Yi David Ju is a Senior Research Fellow at RMIT University's School of Science and an ARC DECRA Fellow at La Trobe University's School of Cancer Medicine. He leads the Nanomedicine and Gene Therapeutics Laboratory at the Olivia Newton-John Cancer Research Institute (ONJCRI) and holds Honorary Fellowships at the University of Melbourne's Department of Microbiology & Immunology and Chemical Engineering. PhD from University of Melbourne (2017, Frank Caruso) 2017–2021 : Research Fellow at University of Melbourne 2021 : Vice-Chancellor’s Postdoctoral Fellow at RMIT 2023 : Visiting Researcher at University of Manchester's Nanomedicine Lab His research focuses on Bio-Nano Interactions , particularly Nanoparticle-Immune System dynamics, Lipid Nanoparticle Engineering for mRNA Delivery , and Poly(ethylene glycol) Alternatives . Key contributions include stealth nanoparticles for prolonged circulation, anti-PEG antibody dynamics in vaccine development, and patient-specific targeting models for chronic lymphocytic leukemia . Recent publications analyze hybrid immuno-PET-MRI probes for inflammation monitoring, zwitterionic PEG nanoparticles for reduced immunogenicity, and RAFT polymer-based LNPs for enhanced gene delivery . His work also explores supramolecular DNA-polyphenol assemblies and metal-phenolic coatings for controlled drug release . Scientific Awards ： 2023 ACIS ECR Lectureship Finalist, 2023 ACS Nano Impact Award 2022&2023 RMIT Enabling Capability Platform Funding 2021 CBNS Most Significant Publication Award 2020 CBNS Career Development Award 2019 Outstanding Postdoctoral Researcher Award 2019 Nanoscale Advances Oral Prize 2017 Reviewer Excellence Award for Chemistry of Materials 2014 Best Tutor Award Professional Roles ： Associate Editor, Journal of Materials Science Committee Member, Royal Australian Chemical Institute (Victorian Branch) Active Member, Australasian Colloid and Interface Society

James Smithمشاهده پروفایل

دانشیار

• Stem Cell Biology
• Cardiovascular Disease
• Gene Editing
• +۷ مورد دیگر

James Smith is an Associate Professor and scientific group leader at Norwich Medical School, University of East Anglia, UK, where he leads research in pluripotent stem cells and cardiovascular disease. He is a member of the Metabolic Health and Cardiovascular and Metabolic Health research groups. Education: PhD in Mesenchymal Stem Cells and Extracellular Matrix, University of Birmingham Post-doctoral training in automated manufacture of human pluripotent stem cells, University of Nottingham His research focuses on using CRISPR gene editing and human induced pluripotent stem cells (hiPSCs) to model and investigate cardiovascular diseases. Key areas include the role of snoRNAs in heart development and disease, cardiomyocyte maturation, and inflammatory responses following cardiac interventions. He established his independent research group at UEA in 2019. The recent publications reflect a strong trend in molecular and cellular cardiology, particularly in non-coding RNA biology, extracellular matrix interactions, and stem cell-based disease modeling. His work bridges basic science with clinical implications, especially in hypertrophic cardiomyopathy and post-intervention inflammation. Scientific Funding & Projects: Identifying novel SNORD116 targets and signalling pathways – Foundation for Prader-Willi Research (2025–2026) Do snoRNAs govern genotype-phenotype interactions in hypertrophic cardiomyopathy? – British Heart Foundation (2023–2027) Dupuytren’s Disease: Genetic variants and cellular phenotype – Action Arthritis (2026–2029) Investigating cardiomyocyte communication in hypertrophic cardiomyopathy – Academy of Medical Sciences (2020–2022) He advises graduate students and early-career researchers in his lab, though specific names are not listed. He has secured competitive grants from major funding bodies and maintains an active laboratory focused on translational cardiovascular research. His work contributes to the UN Sustainable Development Goal 3: Good Health and Well-being. He is based at the Bob Champion Research & Education Building and maintains a lab website at https://www.smithlabuea.com/ .

Florent Ginhouxمشاهده پروفایل

دانشیار مدعو

• Immunology
• Innate Immunity
• Dendritic Cell Biology
• +۳ مورد دیگر

Florent Ginhoux serves as a Senior Principal Investigator at the Singapore Immunology Network (SIgN), A*STAR, and holds adjunct associate professor positions across Singapore's academic landscape including the Yong Loo Lin School of Medicine at National University of Singapore, Duke-NUS Medical School, Skin Research Institute of Singapore, and Nanyang Technological University's School of Biological Sciences, with additional affiliation at Shanghai Immunology Institute. His academic foundation was established in France: Biochemistry degree from University Pierre et Marie Curie (UPMC), Paris VI Masters in Immunology from Pasteur Institute (2000) PhD from UPMC, Paris VI (2004) Following postdoctoral training at Mount Sinai School of Medicine under Dr. Miriam Merad, he joined SIgN in 2009 after serving as Assistant Professor at Mount Sinai. His laboratory pioneers research on dendritic cell and macrophage ontogeny using high-dimensional platforms including RNA sequencing, single-cell transcriptomics, and mass cytometry (CyTOF) to define cell populations by developmental origin and uncover their specialized immune functions. Recognized as an EMBO Young Investigator, his work bridges fundamental immunology with therapeutic applications for immune pathologies. His mentoring includes PhD student Katharine YANG and postdoctoral researchers Satish Tiwari, Sulvania Susanto, Priya Dhami, and William Ho. The lab actively collaborates on immunomonitoring projects leveraging SIgN's advanced platforms for high-dimensional immune profiling in both human and murine systems.

Lars Björckمشاهده پروفایل

استاد

• Protein Biochemistry
• Immunology and Microbiology
• Genetics and Molecular Biology
• +۳ مورد دیگر

Lars Björck is a Professor and Associate Professor in Infection Medicine at Lund University’s Faculty of Medicine, affiliated with the BMC (Clinical Sciences Lund) campus. He serves as a Project Manager for Molecular Pathogenesis and a researcher in the epIgG and Infect@LU research groups. His work focuses on bacterial pathogenesis, immune modulation, and infectious disease mechanisms. Key research areas include Streptococcus pyogenes proteinases (e.g., IdeS), antibody interactions, and bacterial evasion of host immune responses. Research interests span bacterial protein function, antibody inactivation mechanisms, and vaccine development. His projects include studying immune modulating proteins (SIC and IdeS) and developing monoclonal antibodies against streptococcal pathogens. He has contributed to over 135 research outputs, with recent work emphasizing Streptococcal proteins’ roles in immune evasion and inflammatory responses. Lars Björck has led major projects such as the Hygieia initiative, a collaborative effort to develop strategies for infectious disease prevention and treatment. His research bridges molecular biology, immunology, and clinical applications, with a focus on translating findings into therapeutic solutions for infectious diseases.

Tohru Fukaiمشاهده پروفایل

استاد

• Oxidative stress
• Cardiovascular disease
• Metabolic disease
• +۷ مورد دیگر

Tohru Fukai is a Professor and holds the Barbara A. Schnuck Endowed Chair in Translational Medicine at the Medical College of Georgia, Augusta University, where he serves in the Department of Pharmacology and Toxicology. His research is centered at the Vascular Biology Center, where he leads a productive laboratory investigating the molecular mechanisms of oxidative stress and dysfunctional copper metabolism in cardiovascular and metabolic diseases. Dr. Fukai earned his MD in 1988 and PhD in Medical Science in 1995, both from Kyushu University in Japan. Following his medical and doctoral training, he completed postdoctoral fellowship at Emory University School of Medicine in Atlanta from 1995-1999. His research focuses on oxidative stress in cardiovascular and metabolic disease pathogenesis, particularly investigating the role of extracellular SOD (ecSOD, SOD3) and copper transport proteins. His lab has pioneered research on copper transport proteins CTR1, Atox1, and ATP7A in regulating vascular function, demonstrating their critical roles in hypertension, vascular remodeling, inflammatory angiogenesis, atherosclerosis, and diabetes. Notably, his team discovered that copper chaperone Atox1 functions as a copper-dependent transcription factor regulating cell proliferation and inflammatory responses. Analysis of Dr. Fukai's recent publications reveals a strong focus on the intersection of redox signaling, copper metabolism, and vascular function. His work increasingly explores how oxidative stress and copper transport mechanisms contribute to conditions like diabetes, atherosclerosis, Alzheimer's disease, and ischemic injury. A prominent theme across his recent work is the role of protein modifications (particularly sulfenylation and SUMOylation) in regulating vascular responses to oxidative stress, with significant implications for therapeutic interventions. Dr. Fukai's scientific achievements have been recognized with numerous awards including the Barbara A. Schnuck Endowed Chair in Translational Medicine (2017), World Science Leaders in Human Biology Program (2021), and multiple Circulation Research Reviewer Awards. He has served on editorial boards for prestigious journals including Scientific Reports, Journal of Molecular and Cellular Cardiology, and American Journal of Physiology-Heart and Circulatory Physiology. As a mentor, Dr. Fukai has advised numerous graduate students and postdoctoral fellows, including several who have received AHA awards and trainee recognition. He serves on various committees including the VBC post-doc evaluation committee and the CNVAMC Subcommittee for Research Safety. His lab has secured significant funding, including a recent $11.3 million NIH grant for vascular disease research. Dr. Fukai leads an active research group at the Vascular Biology Center comprising senior research associates, assistant research scientists, postdoctoral fellows, and graduate students working collaboratively on multiple projects related to copper transport, redox signaling, and vascular disease mechanisms. His lab has made seminal contributions to understanding how copper transport proteins function as key regulators of vascular antioxidant enzymes and as unexpected signaling molecules in inflammatory disease processes.

Craig Morrellمشاهده پروفایل

استاد

• Platelet Biology
• Vascular Inflammation
• Thrombosis
• +۵ مورد دیگر

Craig Morrell is a Professor at the University of Rochester School of Medicine and Dentistry , with joint appointments in the Departments of Medicine , Microbiology and Immunology , and Pathology and Laboratory Medicine . He serves as Associate Director of the Aab Cardiovascular Research Institute . Education: Sc.B. in Biology, Brown University (1995) D.V.M. , Tufts University School of Veterinary Medicine (2000) Ph.D. in Pathobiology, Johns Hopkins University (2005) His research examines the interface between platelets, vascular biology, and immune cells , focusing on platelet roles in thrombosis, inflammation, and immune regulation. Using advanced mouse models , his lab investigates platelet-derived mediators like β2M and PF4 in diseases such as malaria, stroke, and myocardial infarction. Article trends highlight platelets' dual roles in thrombosis and immune modulation , with recurring themes in vascular inflammation , ERK5 signaling , and age-related immune dysfunction . Scientific Awards: Kenneth M. Brinkous Young Investigators Prize (2008) Deans Gift research award (2006) Multiple travel scholarships and fellowships (2003-2005) Pathology Award-Excellence in Pathology (2000) Mentoring and Teaching : He has mentored 8 doctoral students , 7 undergraduates , and 6 postdoctoral fellows , with a focus on diversity. He serves on thesis committees and the URMC MSTP (MD/PhD) admissions committee . Labs and Collaborations : Leads the Morrell Lab at the Aab Cardiovascular Research Institute, collaborating with institutions like Johns Hopkins and Medical College of Wisconsin.

Dirk Repsilberمشاهده پروفایل

استاد

• Functional Bioinformatics
• Molecular Networks
• Medical Data Analysis
• +۵ مورد دیگر

Dirk Repsilber is a Professor of Medical Science at Örebro University, specializing in functional bioinformatics. He leads research on molecular patterns in patients to improve diagnosis and treatment. Born in Lübeck, Germany, he earned his PhD in ecological genetics from the University of Hamburg and held postdoctoral roles at institutions across Sweden and Germany. His work integrates bioinformatics, biostatistics, and clinical collaboration to address complex biological systems. Education: PhD in Ecological Genetics (University of Hamburg, 1999), postdoctoral training at Uppsala University and SLU, followed by roles at German institutions including Lübeck, Potsdam, Rostock, and Örebro. Research Interests: Molecular networks, biosignature development, systems biology approaches to genotype-phenotype mapping, and interdisciplinary collaborations in medicine, statistics, and computer science. Key Projects: BIO IBD (biomarker discovery in inflammatory bowel disease), Cell Painting for toxicity assessment, and systems-level immunomonitoring in pediatric oncology. Active in cross-disciplinary teams like the Center for Life Sciences Nutrition-Gut-Brain Interactions. Teaching & Supervision: Cross-disciplinary courses in bioinformatics, statistical counseling, and supervision of PhD students in diverse fields. Emphasizes problem-based learning and communication skills across disciplines.

Gary K. Owensمشاهده پروفایل

استاد

• Cardiovascular Biology
• Atherosclerosis
• Smooth Muscle Cell Biology
• +۴ مورد دیگر

Dr. Gary K. Owens is a Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia , with a secondary appointment in the Department of Medicine, Division of Cardiology. He serves as Director of the Robert M. Berne Cardiovascular Research Center and leads groundbreaking research on vascular smooth muscle cell (SMC) dynamics in atherosclerosis. His work challenges conventional paradigms about SMC roles in plaque stability and thromboembolic events. Primary Affiliation: University of Virginia Key Titles: Robert M. Beirne Professor of Cardiovascular Research, Professor, Director of CVRC Research Themes include: Cardiovascular Biology Atherosclerosis Pathogenesis Smooth Muscle Cell Plasticity Epigenetic Regulation Inflammatory Signaling Tumor Metastasis Mechanisms Publication Trends (2015–2024) reveal expertise in Nature Medicine and Circulation studies, focusing on SMC gene regulation (Klf4/Oct4), plaque stability, and cross-talk between vascular cells and tumors. His work demonstrates that SMCs account for >80% of advanced lesion cells and that Klf4 inhibition reduces metastasis by >70%. Lab Leadership includes mentoring PhD students Anita Salamon and Victoria Milosek , alongside senior scientists and postdocs. Collaborations span with Dr. Gwen Randolph (Washington University) and Dr. Rosey Kaplan (NIH) on IL1β signaling and metastasis.

Cornelius Faberمشاهده پروفایل

استاد

• MRI cell tracking
• infection imaging
• MR methodology
• +۶ مورد دیگر

Cornelius Faber is a University Professor in the Department of Radiology at the University of Münster, Germany, where he leads the Experimental Nuclear Magnetic Resonance research group. His work focuses on developing and implementing novel MRI techniques that extend the boundaries of magnetic resonance imaging in terms of spatial and temporal resolution, sensitivity, and specificity for physiological, structural, and molecular changes. He actively participates in the "Cells in Motion" interdisciplinary research initiative at the university. Professor Faber's research spans multiple critical areas in medical imaging and biomedical science. His primary expertise lies in MRI cell tracking , enabling visualization of cellular dynamics in vivo. He has made significant contributions to infection imaging , developing methods to detect and characterize microbial infections using MRI. His work on MR methodology development has advanced quantitative imaging techniques, while his research on multimodal integration in MR and MRI contrast mechanisms has provided deeper insights into molecular and cellular processes. His research bridges physics, engineering, and biomedical applications, with particular relevance to inflammation, cancer, neurological disorders, and cardiovascular disease. Analysis of Professor Faber's extensive publication record reveals a clear evolution from fundamental MRI technique development toward increasingly sophisticated applications in disease models. His recent work demonstrates a strong trend toward multimodal imaging approaches that combine MRI with complementary techniques such as mass spectrometry, optical imaging, and PET. This integration creates comprehensive diagnostic platforms that provide both anatomical and molecular information. A notable pattern is the focus on cellular dynamics, particularly immune cell behavior in inflammatory conditions and tumor microenvironments, with applications spanning neuroscience, oncology, and cardiology. Professor Faber leads a multidisciplinary research team of approximately 15 members, including scientists, doctoral students, technicians, and medical students. His laboratory is deeply integrated with the University of Münster's research infrastructure, particularly the Multiscale Imaging Centre. The group's work contributes significantly to advancing preclinical MRI methodologies while maintaining strong clinical relevance, with numerous publications in high-impact journals across medical imaging, neuroscience, and biomedical engineering disciplines.